Biological complexities in radiation carcinogenesis and cancer radiotherapy: Impact of new biological paradigms

Genes

Volumn 3, Issue 1, 2012, Pages 90-114

  Mozdarani, Hossein ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Bystander effect; Genome instability; Radiation carcinogenesis; Radio adaptation; Radiosensitivity

Indexed keywords

ATM PROTEIN; BRCA2 PROTEIN; CYTOKINE; DNA; GROWTH FACTOR; HELICASE; NIBRIN; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ATAXIA TELANGIECTASIA; BREAST CANCER; BYSTANDER EFFECT; CANCER CONTROL; CANCER PREVENTION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CELLULAR IMMUNITY; DISORDERS OF DNA SYNTHESIS AND REPAIR; GENE AMPLIFICATION; GENOMIC INSTABILITY; HETEROZYGOSITY LOSS; HUMAN; IONIZING RADIATION; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR BIOLOGY; PREDICTION; RADIATION CARCINOGENESIS; RADIATION DOSE; RADIATION FIELD; RADIATION HAZARD; RADIOSENSITIVITY; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID PAPILLARY CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 84858837461     PISSN: None     EISSN: 20734425     Source Type: Journal    
DOI: 10.3390/genes3010090     Document Type: Review

References (200)

1. Upton, A.C. Historical perspective on radiation carcinogenesis. In Radiation Carcinogenesis; Upton, A.C., Alber, R.E., Burns, F.J., Shore, R.E., Eds.; Elsevier: New York, NY, USA, 1986; pp. 1-10.
2. Jacob, P.; Bogdanova, T.I.; Buglova, E.; Chepurniy, M.; Demidchik, Y.; Gavrilin, Y.; Kenigsberg, J.; Meckbach, R.; Schotola, C, Shinkarev, S.; et al. Thyroid cancer risk in areas of Ukraine and Belarus affected by the Chernobyl accident. Radiat. Res. 2006, 165, 1-8.
3. National Research Council. Health Effects of Exposure to Low Levels of Ionizing Radiation, BEIR V; National Academy Press: Washington, DC, USA, 1990.
4. Shadley, J.D.; Wolff, S. Very low doses of X-rays can cause human lymphocytes to become less susceptible to ionizing radiation. Mutagenesis 1987, 2, 95-96.
5. Wang, Z.; Saigusa, S.; Sasaki, M.S. Adaptive response to chromosome damage incultured human lymphocytes primed with low doses of X-rays. Mutat. Res. 1991, 246, 179-186.
6. Mortazavi, S.M.J.; Mozdarani, H. The search for a possible optimum adapting dose under the optimum irradiation time scheme in cultured human lymphocytes. Int. J. Low Radiat. 2006, 3, 74-82.
7. Morgan, W.F.; Sowa, M.B. Non-targeted bystander effects induced by ionizing radiation. Mutat. Res. 2007, 616, 159-164.
8. Bowater, R.; Doherty, A.J. Making ends meet: Repairing breaks in bacterial DNA by non-homologous end-joining. PloS Genet. 2006, 2, e8.
9. Iliakis, G.; Wu, W.; Wang, M.; Terzoudi, G.I.; Pantelias, G.E. Backup pathways of nonhomologous end joining may have a dominant role in the formation of chromosome aberrations. In Chromosmeal Alterations: Methods, Results and Importance in Human Health; Obe, G., Vijayalaxmi, Eds.; Springer-Verlag: Berlin, Germany, 2007; pp. 67-85.
10. Obe, G.; Pfeiffer, P.; Savage, J.R.K.; Johannes, C.; Goedecke, W.; Jeppesen, P.; Natarajan, A.T.; Martinez-Lopez, W.; Folle, G.A.; Derts, M.E. Chromosomal aberrations: Formation, identification and distribution. Mutat. Res. 2002, 504, 17-36.
11. Goedeccke, W. Double starnd break repair mechanisms in mammalian cells. In Chromoosmeal Alterations: Methods, Results and Importance in Human Health; Obe, G., Vijayalaxmi, Eds.; Springer-Verlag: Berlin, Germany, 2007; pp. 55-66.
12. Heyer, W.D.; Li, X.; Rolfsmeier, M.; Zhang, X.P. Rad54: The Swiss Army Knife of homologous recombinations? Nucleic Acids Res. 2006, 34, 4115-4125.
13. Ruis, B.L.; Fattah, K.R.; Hendrickson, E.A. The catalytic subunit of DNA-dependent protein kinase regulates proliferation, telomere length, and genomic stability in human somatic cells. Mol. Cell Biol. 2008, 28, 6182-6195.
14. Fukasawa, K.; Wiener, F.; Vande Woude, G.F.; Mai, S. Genomic instability and apoptosis are frequent in p53 deficient young mice. Oncogene 1997, 15, 1295-1302.
15. Brusa, G.; Benvenuti, M.; Mazzacurati, L.; Mancini, M.; Pattacini, L.; Martinelli, G.; Barbieri, E.; Greenberger, J.S.; Baccarani, M.; Santucci, M.A. p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase. Haematologia 2003, 88, 622-630.
16. Dimitrova, N.; de Lange, T. Cell cycle-dependent role of MRN at dysfunctional telomeres: ATM signaling-dependent induction of nonhomologous end joining (NHEJ) in G1 and resection-mediated inhibition of NHEJ in G2. Mol. Cell Biol. 2009, 29, 5552-5563.
17. Greenwood, J.; Cooper, J.P. Trapping Rap1 at the telomere to prevent chromosome end fusions. EMBO J. 2009, 28, 3277-3278.
18. Bailey, S.M.; Meyne, J.; Chen, D.J.; Kurimasa, A.; Li, G.C.; Lehnert, B.E.; Goodwin, E.H. DNA double-strand break repair proteins are required to cap the ends of mammalian chromosomes. Proc. Natl. Acad. Sci. USA 1999, 96, 14899-14904.
19. Hsiao, S.J.; Smith, S. Sister telomeres rendered dysfunctional by persistent cohesion are fused by NHEJ. J. Cell Biol. 2009, 184, 515-526.
20. Bender, M.A.; Griggs, H.G.; Bedford, J.S. Mechanisms of chromosomal aberration production: III. Chemical and ionizing radiation. Mutat. Res. 1974, 23, 197-212.
21. Natarajan, A.T.; Obe, G.; van Zeeland, A.A.; Palitti, F.; Meijers, M.; Verdegaal-Immerzell, E.A.M. Molecular mechanisms involved in the production of chromosomal aberrations. II. Utilization of Neurospora endonuclease for the study of aberration production by X-rays in G1 and G2 stages of the cell cycle. Mutat. Res. 1980, 69, 293-305.
22. Mozdarani, H.; Bryant, P.E. The effects of 9-b-D arabinofuranosylanine on the formation of X-ray induced chromatid aberrations in X-irradiated G2 human cells. Mutagenesis 1987, 2, 371-374.
23. Mozdarani, H.; Bryant, P.E. Induction and rejoining of chromatid breaks in X-irradiated A-T and normal human G2 fibroblasts. Int. J. Radiat. Biol. 1989, 56, 645-659.
24. Kemp, L.M.; Jeggo, P.A. Radiation induced chromosome damage in X-ray sensitive mutants (xrs) of the Chinese hamster ovary cell line. Mutat. Res. DNA Repair Rep.1986, 166, 255-263.
25. Bryant, P.E.; Birch, D.A.; Jeggo, P.A. High chromosomal sensitivity of Chinese hamster xrs5 cells to restriction endonuclease induced DNA dsb. Int. J. Radiat. Biol. 1987, 52, 537-554.
26. Bryant, P.E.; Finnegan, C.E.; Mozdarani, H. G2 chromatid breaks in murine scid cells. Mutagenesis 1998, 13, 481-485.
27. Natarajan, A.T.; Obe, G. Molecular mechanisms involved in the production of chromosomal aberrations. III. Restriction endonucleases. Chromosoma 1984, 90, 120-127.
28. Bryant, P.E. Use of restriction endonucleases to study relationship between DNA double strand breaks, chromosomal aberrations and other end points in mammalian cells. Int. J. Radiat. Biol. 1988, 54, 869-890.
29. Heim, S.; Mitelman, F. Cancer Cytogenetics, 3rd ed.; Wiley-Blackwell: Hoboken, NJ, USA, 2009.
30. Fusco, A.; Santoro, M. 20 years of RET/PTC in thyroid cancer: Clinico-pathological correlations. Arq. Bras. Endocrinol. Metabol. 2007, 51, 731-735.
31. Viglietto, G.; Chiappetta, G.; Martinez-Tello, F.J.; Fukunaga, F.H.; Tallini, G; Rigopoulou, D.; Visconti, R.; Mastro, A.; Santoro, M.; Fusco, A. RET/PTC oncogene activation is an early event in thyroid carcinogenesis. Oncogene 1995, 11, 1207-1210.
32. Nikiforova, M.N.; Stringer, J.R.; Blough, R.; Medvedovic, M.; Fagin, J.A.; Nikiforov, Y.E. Proximity of chromoso-mal loci that participate in radiation-induced rearrangements in human cells. Science 2000, 290, 138-141.
33. Nikiforov, Y.; Rowland, J.M.; Bove, K.E.; Monfore Munoz, H.; Fagin, J.A. Distinct patterns of ret rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res. 1997, 57, 1690-1694.
34. Santoro, M.; Melillo, R.M.; Fusco, A. RET/PTC activation in papillary thyroid carcinoma. Eur. J. Endocrinol. 2006, 155, 645-653.
35. Elisei, R.; Romel, C.; Vorontsova, T.; Cosci, B.; Veremeychick, V.; Kuchinskaya, E.; Basolo, F.; Demidchik, E.P.; Miccoli, P.; Pinchera, A.; et al. RET/PTC rearrangments in tyroid nodules: Studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. J. Clin. Endocrinol. Metab. 2001, 86, 3211-3216.
36. Hagmar, L.; Stromberg, U.; Bonassi, S.; Hansteen, I.L.; Knudsen, L.E.; Lindholm, C.; Norppa, H. Impact of types of lymphocyte chromosomal aberrations on human cancer risk: Results from Nordic and Italian cohorts. Cancer Res. 2004, 64, 2258-2263.
37. Bonassi, S.; Abbondandolo, A.; Camurri, L.; Dal Prá, L.; de Ferrari, M.; Degrassi, F.; Forni, A.; Lamberti, L.; Lando, C.; Padovani, P.; et al. Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet. Cytogenet. 1995, 79, 133-135.
38. Rabbitts, T.H. Chromosomal translocations in human cancer. Nature 1994, 372, 143-149.
39. Auletta, A.; Ashby, J. Workshop on the relationship between short-term information and carcinogenicity. Environ. Mol. Mutagen. 1988, 11, 135-145.
40. Shelby, M. The genetic toxicity of human carcinogens and its implications. Mutat. Res. 1988, 204, 3-15.
41. Au, W.W.; Lane, R.G.; Legator, M.S.; Whorton, E.B.; Wilkinson, G.S.; Gaberhort, G.J. Biomarker monitoring of a population residing near uranium mining activities. Environ. Health Perspect. 1995, 103, 466-470.
42. Mondello, C.; Smirnova, A.; Giulotto, E. Gene amplification, radiation sensitivity and DNA double-strand breaks. Mutat. Res. 2010, 704, 29-37.
43. ICRP. Annual Report of the International Commission on Radiological Protection; Elsevier Science: New York, NY, USA, 1999.
44. Djuzenova, C.S.; Muhl, B.; Fehn, M.; Oppitz, U.; Muller, B.; Flentje, M. Radiosensitivity in breast cancer assessed by the Comet and micronucleus assays. Br. J. Cancer 2006, 94, 1194-1203.
45. Shahidi, M.; Mozdarani, H.; Bryant, P.E. Radiation sensitivity of leukocytes from healthy individuals and breast cancer patients as measured by the alkaline and neutral comet assay. Cancer Lett. 2007, 257, 263-273.
46. Shahidi, M.; Mozdarani, H.; Mueller, W.U. Radiosensitivity and repair kinetics of gamma-irradiated leukocytes from sporadic prostate cancer patients and healthy individuals assessed by alkaline comet assay. Iran. Biomed. J. 2010, 14, 67-75.
47. Lengauer, C.; Kinzler, K.W.; Vogelstein, B. Genetic instabilities in human cancers. Nature 1998, 396, 643-649.
48. Thompson, L.H.; Schild, D. Recombinational DNA repair and human disease. Mutat. Res. 2002, 509, 49-78.
49. Rothfuss, A.; Schütz, P.; Bochum, S.; Volm, T.; Eberhardt, E.; Kreienberg, R.; Vogel, W.; Speit, G. Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer Res. 2000, 60, 390-394.
50. Carney, J.P. Chromosomal breakage syndromes. Curr. Opin. Immunol. 1999, 11, 443-447.
51. Pichierri, P.; Franchitto, A.; Palitti, F. Predisposition to cancer and radiosensitivity. Genet. Mol. Biol. 2000, 23, 1101-1105.
52. Mohseni, A.; Mozdarani, H.; Mozdarani, S. DNA damage and repair of leukocytes from Fanconi anemia patients, carriers and healthy individuals as measured by the alkaline comet assay. Mutagenesis 2009, 24, 67-73.
53. Taylor, A.M.R. Chromosome instability syndromes. Best Pract. Res. Clin. Haematol. 2001, 14, 3631-3644.
54. Duker, N.J. Chromosome breakage syndromes and cancer. Am. J. Med. Genet. 2002, 115, 125-129.
55. Higurashi, M.; Conen, P.E. In vitro chromosomal radiosensitivity in chromosomal breakage syndromes. Cancer 1973, 32, 380-383.
56. Lavin, M.F.; Shiloh, Y. The genetic defect in ataxia-telangiectasia. Ann. Rev. Immunol. 1997, 15, 177-202.
57. Carney, J.P.; Maser, R.S.; Olivares, H.; Davis, E.M.; Le Beau, M.; Yates, J.R., III; Hays, L.; Morgan, W.F.; Petrini, J.H.J. The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: Linkage of double-strand break repair to the cellular DNA damage response. Cell 1998, 93, 477-486.
58. Varon, R.; Vissinga, C.; Platzer, M.; Cerosaletti, K.M.; Chrzanowska, K.H.; Saar, K.; Beckmann, G.; Seemanová, E.; Cooper, P.R.; Nowak, N.J.; et al. Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 1998, 93, 467-476.
59. Stewart, G.S.; Maser, R.S.; Stankovic, T.; Bressan, D.A.; Kaplan, M.I.; Jaspers, N.G.J.; Raams, A.; Byrd1, P.J.; Petrini, J.H.J.; Taylor, A.M.R. The DNA double-strand break repair gene hmre11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell 1999, 99, 577-587.
60. Ellis, N.A.; Groden, J.; Ye, T-Z.; Straughen, J.; Lennon, D.J.; Ciocci, S.; Proytcheva, M.; German, J. The Bloom's syndrome gene product is homologous to RecQ helicases. Cell 1995, 83, 655-666.
61. Gray, M.D.; Shen, J.C.; Kamath-Loeb, A.S.; Blank, A.; Sopher, B.L.; Martin, G.M.; Oshima, J.; Loeb, L.A. The Werner syndrome protein is a DNA helicase. Nat. Genet. 1997, 17, 100-103.
62. Howlett, N.G.; Taniguchi, T.; Olson, S.; Cox, B.; Waisfisz, Q.; de Die-Smulders, C.; Persky, N.; Grompe, M.; Joenje, H.; Pals, G.; et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 2002, 297, 606-609.
63. Patel, K.J.; Yu, V.P.; Lee, H.; Corcoran, A.; Thistlethwaite, F.C.; Evans, M.J.; Colledge, W.H.; Friedman, L.S.; Ponder, B.A.; Venkitaraman, A.R. Involvement of Brca2 in DNA repair. Mol. Cell. 1998, 1, 347-357.
64. Stewart, G.; Elledge, S.J. The two faces of BRCA2, a FANCtastic discovery. Mol. Cell. 2002, 10, 2-4.
65. Meybodi, M.A.; Mozdarani, H.; Vosogh, P. Cytogenetic sensitivity of G0 lymphocytes of Fanconi anemia patients and obligate carriers to mytomycin C and ionizing radiation. Cytogenet. Genome Res. 2007, 119, 191-195.
66. Meybodi, M.A.; Mozdarani, H. DNA Damage in leukocytes from fanconi anemia (FA) patients and heterozygotes induced by mitomycin C and ionizing radiation as assessed by the comet and comet-FISH assay. Iran. Biomed. J. 2009, 13, 1-8.
67. Sanford, K.K.; Parshad, R.; Price, F.M.; Gantt, R.; Jones, G.M.; Tarone, R.E. Deficient G2 phase repair of radiation-induced chromatin damage in the SENCAR mouse. Carcinogenesis 1989, 10, 1911-1916.
68. Sanford, K.K.; Parshad, R.; Gantt, R.R.; Tarone, R.E. A deficiency in chromatin repair, genetic instability, and predisposition to cancer. Crit. Rev. Oncog. 1989, 1, 323-341.
69. Parshad, R.; Price, F.M.; Bohr, V.A.; Cowans, K.H.; Zujewski, J.A.; Sanford, A.A. Deficient DNA repair capacity, a predisposing factor in breast cancer. Br. J. Cancer 1996, 74, 1-5.
70. Baeyens, A.; Thierens, H.; Claes, K.; Poppe, B.; Messiaen, L.; de Ridder, L.; Vral, A. Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition. Br. J. Cancer 2002, 87, 1379-1385.
71. Scott, D. Chromosomal radiosensitivity and low penetrance predisposition to cancer. Cytogenet. Genome Res. 2004, 104, 365-370.
72. Scott, D.; Barber, J.B.; Spreadborough, A.R.; Burrill, W.; Roberts, S.A. Increased chromosomal radiosensitivity in breast cancer patients: A comparison of two assays. Int. J. Radiat. Biol. 1999, 75, 1-10.
73. Sánchez, P.; Peñarroja, R.; Gallegos, F.; Bravo, J.L.; Rojas, E.; Benítez-Bribiesca, L. DNA damage in peripheral lymphocytes of untreated breast cancer patients. Arch. Med. Res. 2004, 35, 480-483.
74. Mozdarani, H.; Mansouri, Z.; Haeri, S.A. Cytogenetic radiosensitivity of G0-lymphocytes of breast and esophageal cancer patients using the micronucleous assay. J. Radiat. Res. 2005, 46, 111-116.
75. Helzlsouer, K.J.; Harris, E.L.; Parshad, R.; Perry, H.R.; Price, F.M.; Sanford, K.K. DNA repair proficiency: Potential susceptiblity factor for breast cancer. J. Natl. Cancer Inst. 1996, 88, 754-755.
76. Patel, R.K.; Trivedi, A.H.; Arora, D.C.; Bhatavdekar, J.M.; Patel, D.D. DNA repair proficiency in breast cancer patients and their first-degree relatives. Int. J. Cancer 1997, 73, 20-24.
77. Cybulski, C.; Huzarski, T.; Górski, B.; Masojć, B.; Mierzejewski, M.; Debniak, T.; Gliniewicz, B.; Matyjasik, J.; Złowocka, E.; Kurzawski, G.; et al. A novel founder CHEK2 mutation is associated with increased prostate cancer risk. Cancer Res. 2004, 64, 2677-2679.
78. Angèle, S.; Jones, C.; Reis Filho, J.S.; Fulford, L.G.; Treilleux, I.; Lakhani, S.R.; Hall, J. Expression of ATM, p53, and the MRE11-Rad50-NBS1 complex in myoepithelial cells from benign and malignant proliferations of the breast. J. Clin. Pathol. 2004, 57, 1179-1184.
79. Edwards, S.M.; Kote-Jarai, Z.; Meitz, J.; Hamoudi, R.; Hope, Q.; Osin, P.; Jackson, R.; Southgate, C.; Singh, R.; Falconer, A.; Dearnaley, D.P.; et al. Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. Am. J. Hum. Genet. 2003, 72, 1-12.
80. Parshad, R.; Sanford, K.K.; Jones, G.M. Chromatid damage after G2 phase x-irradiation of cells from cancer-prone individuals implicates deficiency in DNA repair. Proc. Natl. Acad. Sci. USA 1983, 80, 5612-5616.
81. Sanford, K.K.; Parshad, R.; Stanbridge, E.J.; Frost, J.K.; Jones, G.M.; Wilkinson, J.E.; Tarone, R.E. Chromosomal radiosensitivity during the G2 cell cycle period and cytopathology of human normal × tumor cell hybrids. Cancer Res. 1986, 46, 2045-2049.
82. Mozdarani, H.; Liu, N.; Jones, N.J.; Bryant, P.E. The XRCC2 human repair gene influences recombinational rearrangements leading to chromatid breaks. Int. J. Radiat. Biol. 2001, 77, 859-865.
83. Terzoudi, G.I.; Hatzi, V.I.; Donta-Bakoyianni, C; Pantelias, G.E. Chromatin dynamics during cell cycle mediate conversion of DNA damage into chromatid breaks and affect formation of chromosomal aberrations: Biological and clinical significance. Mutat. Res. 2011, 711, 174-186.
84. Belyaev, I.Y. Radiation-induced DNA repair foci: Spatio-temporal aspects of formation, application for assessment of radiosensitivity and biological dosimetry. Mutat. Res. 2010, 704, 132-141.
85. Alsbeih, G.; Al-Harbi, N.; Al-Buhairi, M.; Al-Hadyan, K.; Al-Hamed, M. Association between TP53 codon 72 single-nucleotide polymorphism and radiation sensitivity of human fibroblasts. Radiat. Res. 2007, 167, 535-540.
86. Andreassen, C.N.; Alsner, J.; Overgaard J. Does variability in normal tissue reactions after radiotherapy have a genetic basis-Where and how to look for it? Radiother. Oncol. 2002, 64, 131-140.
87. Andreassen, C.N.; Alsner, J. Genetic variants and normal tissue toxicity after radiotherapy: A systematic review. Radiother. Oncol. 2009, 92, 299-309.
88. Rosenstein, B.S. Identification of SNPs associated with susceptibility for development of adverse reactions to radiotherapy. Pharmacogenomics 2011, 12, 267-275.
89. Azria, D.; Ozsahin, M.; Kramar, A.; Peters, S.; Atencio, D.P.; Crompton, N.E.A.; Mornex, F.; Pèlegrin, A.; Dubois, J.B.; Mirimanoff, R.O.; et al. Single nucleotide polymorphisms, apoptosis and the development of severe late adverse effects after radiotherapy. Clin. Cancer Res. 2008, 14, 6284-6288.
90. Michikawa, Y.; Suga, T.; Ishikawa, A.; Hayashi, H.; Oka, A.; Inoko, H.; Iwakawa, M.; Imai, T. Genome wide screen identifies microsatellite markers associated with acute adverse effects following radiotherapy in cancer patients. BMC Med. Genet. 2010, 11, 123.
91. Luckey, T.D. Radiation Hormesis; CRC Press: Boca Raton, FL, USA, 1991.
92. Jolly, D.; Meyer, J. A brief review of radiation hormesis. Australas. Phys. Eng. Sci. Med. 2009, 32, 180-187.
93. Muckerheide, J. Low-Level Radiation Health Effects: A Compilation of Data and Programs; RSH Inc.: Needham, MA, USA, 2001.
94. McClintock, B. The significance of responses of the genome to challenge. Science 1984, 226, 792-801.
95. Serebriany̌, A.M. Radiation adaptive response as a stress reaction of a cell (in Russian). Radiats. Biol. Radioecol. 2011, 51, 399-404.
96. Samson, L.; Cairns, J. A new pathway for DNA repair in Escherichia coli. Nature 1977, 267, 281-283.
97. Laval, F.; Laval, J. Adaptive response in mammalian cells: Crossreactivity of different pretreatments on cytotoxicity as contrasted to mutagenicity. Proc. Natl. Acad. Sci. USA 1984, 81, 1062-1066.
98. Olivieri, G.; Bodycote, J.; Wolff, S. Adaptive response of human lymphocytes to low concentrations of radioactive thymidine. Science 1984, 223, 594-597.
99. Wolff, S. Failla Memorial Lecture. Is radiation all bad? The search for adaptation. Radiat. Res. 1992, 131, 117-123.
100. Wolff, S. The adaptive response in radiobiology: Evolving insights and implications. Environ. Health Perspect. 1998, 106, S277-S283.
101. Rigaud, O.; Moustacchi, E. Radioadaptation for gene mutation and the possible molecular mechanisms of the adaptive response. Mutat. Res. 1996, 358, 127-134.
102. Stoilov, L.M.; Mullenders, L.H.; Darroudi, F.; Natarajan, A.T. Adaptive response to DNA and chromosomal damage induced by X-rays in human blood lymphocytes. Mutagenesis 2007, 22, 117-122.
103. Bryant, P.E. Origin of chromosome anerrations: Mechanisms. In Chromoosmeal Alterations: Methods, Results and Importance in Human Health; Obe, G., Vijayalaxmi, Eds.; Springer-Verlag: Berlin, Germany, 2007; pp. 177-199.
104. Bryant, P.E.; Mozdarani, H. Mechanisms underlying the conversion of DNA double strand breaks into chromatid breaks. Int. J. Low Radiat. 2004, 1, 223-230.
105. Tedeschi, B.; Caporossi, D.; Vernole, P.; Padovani, L.; Appolloni, M.; Anzidei, P.; Mauro, F. Do human lymphocytes exposed to the fallout of the Chernobyl accident exhibit an adaptive response? II. Challenge with bleomycin. Mutat. Res. 1995, 332, 39-44.
106. Mozdarani, H.; Saberi, A.H. Induction of cytogenetic adaptive response of bone marrow cells to radiation by therapeutic doses of bleomycin sulfate and actionmycin D as assayed by the micronucleus test. Cancer Lett. 1994, 78, 141-150.
107. Barquinero, J.F.; Barrios, L.; Caballin, M.R.; Miro, R.; Ribas, M. Occupational exposure to radiation induces an adaptive response in human lymphocytes. Int. J. Radiat. Biol. 1995, 67, 187-191.
108. Barquinero, J.F.; Barrios, L.; Caballin, M.R.; Miro, R.; Ribas, M.; Subias, A.; Egozcue, J. Decreased sensitivity to the cytogenetic effects of bleomycin in individuals occupationally exposed to ionizing radiation. Mutat. Res. 1996, 354, 81-86.
109. Gourabi, H.; Mozdarani, H. A cytokinesis blocked micronucleus study of the radiadaptive response of lymphocytes of individuals ocupationally exposed to chronic doses ofradiation. Mutagenesis 1998, 13, 475-480.
110. Mozdarani, H.; Gourabi, H. Chromosomal aberrations and micronuclei in lymphocytes of medical radiation workers exposed to ionizing radiation below dose limit. Yakhteh Med. J. 2001, 3, 153-158.
111. Tedeschi, B. Do human lymphocytes exposed to fall out of Chernobyl accident exhibit an adaptive response. Mutat. Res. 1996, 354, 77-80.
112. Mitchel, R.E.J.; Jackson, J.S.; McCann, R.A.; Boreham, D.R. Adaptive response modification of latency for radiation-induced myeloid leukemia in CBA/H mice. Radiat. Res. 1999, 152, 273-279.
113. Mitchel, R.E.J.; Jackson, J.S.; Morrison, D.P.; Carlisle, S.M. Low doses of radiation increase the latency of spontaneous lymphomas and spinal osteosarcomas in cancer-prone, radiation-sensitive Trp53 heterozygous mice. Radiat. Res. 2003, 159, 320-327.
114. Cohen, B.L. Test of the linear no-threshold theory of radiation carcinogenesis for inhaled radon decay products. Health Phys. 1995, 68, 157-174.
115. Deetjen, P. Biological and therapeutical properties of radon. In Radon and Thoron in the Human Environment; Katase, A., Shimo, M., Eds.; WorldScientific: Singapore, 1998; pp. 515-522.
116. Becker, K. Health effects of high radon environments in central Europe: Another test for the LNT hypothesis. Nonlinearity Biol. Toxicol. Med. 2005, 1, 3-35.
117. Chen, W.L.; Luan, Y.C.; Shici, M.C.; Chen, S.T.; Kung, H.T.; Soong, K.L.; Yeh, Y.C.; Chou, S.H.; Mong, S.H.; Wu, J.T.; et al. Is chronic radiation an effective prophylaxis against cancer? J. Am. Phys. Surg. 2004, 9, 6-10.
118. Sakamoto, K.; Myonin, M.; Hosor, Y.; Ogawa, Y.; Nemoto, K.; Takai, Y.; Kakuto, Y.; Yamada, S.; Watabe, N. Fundamental and clinical studies on cancer control with total or upper half body irradiation. J. Jpn. Soc. Ther. Radiol. Oncol. 1997, 9, 161-175.
119. Aurengo, A.; Averbeck, D.; Bonnin, A.; LeGuen, B.; Masse, R.; Monier, R.; Tubiana, M.; Valleron, A.J.; de Vathaire, F. Dose-Effect Relationships and Estimation of the Carcinogenic Effects of Low Doses of Ionizing Radiation; Academies of Sciences and Medicine: Paris, France, 2005.
120. UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation). Health Effects Due to Radiation from the Chernobyl Accident; Report to the General Assembly with Scientific Annexes, Volume 2, Annex D. United Nations: New York, NY, USA, 2011.
121. Luckey, T.D. Low dose irradiation reduces cancer death rates. Radiat. Protect. Manag. 1997, 14, 58-64.
122. Luckey, T.D. Radiation hormesis in cancer mortality. Int. J. Occup. Med. Tox. 1994, 3, 175-191.
123. Vaiserman, A.M. Radiation hormesis: Historical perspective and implications for low-dose cancer risk assessment. Dose Response 2010, 8, 172-191.
124. Luckey, T.D. Nuclear triage and the dirty bomb. Radiat. Protect. Manag. 2004, 20, 11-18.
125. NEA Committee. Chernobyl: Ten Years on Radiological and Health Impact; Nuclear Energy Agency, OCED (Organization for Economic Co-Operation and Development): Paris, France, 1995.
126. National Research Council. Health Effects of Exposure to Radon, BEIR VI; National Academy Press: Washington, DC, USA, 1999.
127. National Research Council. Health Risks from Exposure to Low Levels of Ionizing Radiation, BEIR VII, Phase 2; National Academy Press: Washington, DC, USA, 2005.
128. Jaworowski, Z. Radiation hormesis-A remedy for fear. Hum. Exp. Toxicol. 2010, 29, 263-270.
129. Azzam, E.I.; Raaphorst, G.P.; Mitchel, R.E.J. Radiation-induced adaptive response for protection against micronucleus formation and neoplastic transformation in C3H 10T1/2 mouse embryo cells. Radiat. Res. 1994, 138, S28-S31.
130. Broome, E.J.; Brown, D.L.; Mitchel, R.E. Dose responses for adaption to low doses of (60)Co gamma rays and (3)H beta particles in normal human fibroblasts. Radiat. Res. 2002, 158, 181-186.
131. Hamada, N.; Maeda, M.; Otsuka, K.; Tomita, M. Signaling pathways underpinning the manifestations of ionizing radiation-induced bystander effects. Curr. Mol. Pharmacol. 2011, 4, 79-95.
132. Feinendegen, L.E.; Bond, V.P.; Booz, J.; Mühlensiepen, H. Biochemical and cellular mechanisms of low-dose effects. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 1988, 53, 23-37.
133. Wolff, S. Are radiation-induced effects hormetic? Science 1989, 245, 575-621.
134. Sankaranarayanan, K.; von Duyn, A.; Loos, M.J.; Natarajan, A.T. Adaptive response of human lymphocytes to low-level radiation from radioisotopes or X-rays. Mutat. Res. 1989, 211, 7-12.
135. Bosi, A.; Olivieri, G. Variability of the adaptive response to ionizing radiations in humans. Mutat. Res. 1989, 211, 13-17.
136. Davalos, A.; Yannone, S.; Kawahara, M.; Campisi, J. Molecular Mediators of Radio-Adaptation in Human Cells. Presented at DOE Low Dose Radiation Research Investigators' Workshop VI, Washington, DC, USA, 30 July-2 August 2006.
137. UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation). Effects of Ionizing Radiation; Report to the General Assembly with Scientific Annexes, Volume 1; United Nations: New York, NY, USA, 2006.
138. Liu, S.Z. Biological effects of low level exposures to ionizing radiation: Theory and practice. Hum. Exp. Toxicol. 2010, 29, 275-281.
139. Baverstock, K. Radiation-induced genomic instability: A paradigm-breaking phenomenon and its relevance to environmentally induced cancer. Mutat. Res. Fund. Mol. Mech. Mutagen. 2000, 454, 89-109.
140. Mothersill, C.; Seymour, C. Radiation-induced bystander effects: Past history and future directions. Radiat. Res. 2001, 155, 757-765.
141. Goldberg, Z.; Lehnert, B.E. Radiation-induced effects in unirradiated cells: A review and implications in cancer. Int. J. Oncol. 2002, 21, 337-349.
142. Lorimore, S.A.; Coates, P.J.; Wright, E.G. Radiation-induced genomic instability and bystander effects: Inter-related nontargeted effects of exposure to ionizing radiation. Oncogene 2003, 22, 7058-7069.
143. Mothersill, C.; Seymour, C. Radiation-induced bystander effects, carcinogenesis and models. Oncogene 2003, 22, 7028-7033.
144. Wright, E.G. Manifestations and mechanisms of non-targeted effects of ionizing radiation. Mutat. Res. 2010, 687, 28-33.
145. Mothersill, C.; Seymour, C. Medium from irradiated human epithelial cells but not human fibroblasts reduces the clonogenic survival of unirradiated cells. Int. J. Radiat. Biol. 1997, 71, 421-427.
146. Lehnert, B.E.; Goodwin, E.H. A new mechanism for DNA alterations induced by alpha particles such as those emitted by radon and radon progeny. Environ. Health Perspect. 1997, 105, 1095-1101.
147. Prise, K.M.; Belyakov, O.V.; Folkard, M.; Michael, B.D. Studies of bystander effects in human fibroblasts using a charged particle microbeam. Int. J. Radiat. Biol. 1998, 74, 793-798.
148. Shao, C.; Stewart, V.; Folkard, M.; Michael, B.D.; Prise, K.M. Nitric oxide-mediated signaling in the bystandard response of individually targeted glioma cells. Cancer Res. 2003, 63, 8437-8442.
149. Lorimore, S.A.; Kadhim, M.A.; Pocock, D.A.; Papworth, D.; Stevens, D.L.; Goodhead, D.T.; Wright, E.G. Chromosomal instability in the descendants of unirradiated surviving cells after alpha-particle irradiation. Proc. Natl. Acad. Sci. USA 1998, 95, 5730-5733.
150. Azzam, E.I.; de Toledo, S.M.; Gooding, T.; Little, J.B. Intercellular communication is involved in the bystander regulation of gene expression in human cells exposed to very low fluences of alpha particles. Radiat. Res. 1998, 150, 497-504.
151. Belloni, P.; Latini, P.; Palitti F. Radiation-induced bystander effect in healthy G0 human lymphocytes: Biological and clinical significance. Mutat. Res. 2011, 713, 32-38.
152. Little, J.B. Cellular radiation effects and the bystander response. Mutat. Res. 2006, 597, 113-118.
153. Kanasugi, Y.; Hamada, N.; Wada, S.; Funayama, T.; Sakashita, T.; Kakizaki, T.; Kobayashi, Y.; Takakura, K. Role of DNA-PKcs in the bystander effect after low- or high-LET irradiation. Int. J. Radiat. Biol. 2007, 83, 73-80.
154. Konopacka, M.; Rzeszowska-Wolny, R.J. The bystander effect-induced formation of micronucleated cells is inhibited by antioxidants, but the parallel induction of apoptosis and loss of viability are not affected. Mutat. Res. 2006, 593, 32-38.
155. Rzeszowska-Wolny, J.; Przybyszewski, W.M.; Widel, M. Ionizing radiation-induced bystander effects, potential targets for modulation of radiotherapy. Eur. J. Pharmacol. 2009, 625, 156-164.
156. Kashino, G.; Suzuki, K.; Matsuda, N.; Kodama, S.; Ono, K.; Watanabe, M.; Prise, K.M. Radiation induced bystander signals are independent of DNA damage and DNA repair capacity of the irradiated cells. Mutat. Res. 2007, 619, 134-138.
157. Sokolov, M.V.; Smilenov, L.B.; Hall, E.J.; Panyutin, I.G.; Bonner, W.M.; Sedelnikova, O.A. Ionizing radiation induces DNA double-strand breaks in bystander primary human fibroblasts. Oncogene 2005, 24, 7257-7265.
158. Harada, T.; Kashino, G.; Suzuki, K.; Matsuda, N.; Kodama, S.; Watanabe, M. Different involvement of radical species in irradiated and bystander cells. Int. J. Radiat. Biol. 2008, 84, 809-814.
159. Sokolov, M.V.; Dickey, J.S.; Bonner, W.M.; Sedelnikova, O.A. Gamma-H2AX in bystander cells: Not just a radiation-triggered event, a cellular response to stress mediated by intercellular communication. Cell Cycle 2007, 6, 2210-2212.
160. Sedelnikova, O.A.; Nakamura, A.; Kovalchuk, O.; Koturbash, I.; Mitchell, S.A.; Marino, S.A.; Brenner, D.J.; Bonner, W.M. DNA double-strand breaks form in bystander cells after microbeam irradiation of three-dimensional human tissue models. Cancer Res. 2007, 67, 4295-4302.
161. Belyakov, O.; Malcolmson, A.; Folkard, M.; Prise, K.; Michael, B. Direct evidence for a bystander effect of ionizing radiation in primary human fibroblasts. Br. J. Cancer 2001, 84, 674-679.
162. Ballarini, F.; Biaggi, M.; Ottolenghi, A.; Sapora, O. Cellular communication and bystander effects: A critical review for modelling low-dose radiation action. Mutat. Res. 2002, 501, 1-12.
163. Prise, K.M.; O'Sullivan, J.M. Radiation-induced bystander signalling in cancer therapy. Nat. Rev. Cancer 2009, 9, 351-360.
164. Lorimore, S.A.; Coates, P.J.; Scobie, G.E.; Milne, G.; Wright, E.G. Inflammatory-type responses after exposure to ionizing radiation in vivo: A mechanism for radiation-induced bystander effects? Oncogene 2001, 20, 7085-7095.
165. Marples, B.; Collis, S.J. Low-dose hyper-radiosensitivity: Past, present, and future. Int. J. Radiat. Oncol. Biol. Phys. 2008, 70, 1310-1318.
166. Iyer, R.; Lehnert, B.E. Low dose, low-LET ionizing radiation-induced radioadaptation and associated early responses in unirradiated cells. Mutat.Res. 2002, 503, 1-9.
167. Rothkamm, K.; Löbrich, M. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc. Natl. Acad. Sci. USA 2003, 100, 5057-5062.
168. Ojima, M.; Ban, N.; Kai M. DNA double-strand breaks induced by very low X-ray doses are largely due to bystander effects. Radiat. Res. 2008, 170, 365-371.
169. Little, M.P. Do non-targeted effects increase or decrease low dose risk in relation to the linear-non-threshold (LNT) model? Mutat. Res. 2010, 687, 17-27.
170. Suit, H.; Goldberg, S.; Niemierko, A.; Ancukiewicz, M.; Hall, E.; Goitein, M.; Wong, W.; Paganetti, H. Secondary carcinogenesis in patients treated with radiation: A review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects. Radiat. Res. 2007, 167, 12-42.
171. Tubiana, M. Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. Radiother. Oncol. 2009, 91, 4-15.
172. Wideł, M.; Przybyszewski, W.; Rzeszowska-Wolny, J. Radiation-induced bystander effect: The important part of ionizing radiation response (in Polish). Potential clinical implications. Postepy Hig. Med. Dosw. (Online) 2009, 63, 377-388.
173. Sjostedt, S.; Bezak, E. Non-targeted effects of ionising radiation and radiotherapy. Australas. Phys. Eng. Sci. Med. 2010, 33, 219-231.
174. Blyth, B.J.; Sykes, P.J. Radiation-induced bystander effects: What are they, and how relevant are they to human radiation exposures? Radiat. Res. 2011, 176, 139-157.
175. Mackonis, E.C.; Suchowerska, N.; Zhang, M.; Ebert, M.; McKenzie, D.R.; Jackson, M. Cellular response to modulated radiation fields. Phys. Med. Biol. 2007, 52, 5469-5482.
176. Iyer, R.; Lehnert, B.E. Effects of ionizing radiation in targeted and nontargeted cells. Arch. Biochem. Biophys. 2000, 376, 14-25.
177. Hei, T.K.; Zhou, H.; Chai, Y.; Ponnaiya, B.; Ivanov, V.N. Radiation induced non-targeted response: Mechanism and potential clinical implications. Curr. Mol. Pharmacol. 2011, 4, 96-105.
178. Mole, R.H. Whole body irradiation-radiobiology or medicine? Br. J. Radiol. 1953, 26, 234-241.
179. Nobler, M.P. The abscopal effect in malignant lymphoma and its relationship to lymphocyte circulation. Radiology 1969, 93, 410-412.
180. Antoniades, J.; Brady, L.W.; Lightfoot, DA. Lymphangiographic demonstration of the abscopal effect in patients with malignant lymphomas. Int. J. Radiat. Oncol. Biol. Phys. 1977, 2, 141-147.
181. Rees, G.J. Abscopal regression in lymphoma: A mechanism in common with total body irradiation? Clin. Radiol. 1981, 32, 475-480.
182. Ehlers, G.; Fridman, M. Abscopal effect of radiation in papillary adenocarcinoma. Br. J. Radiol. 1973, 46, 220-222.
183. Kingsley, D.P. An interesting case of possible abscopal effect in malignant melanoma. Br. J. Radiol. 1975, 48, 863-866.
184. Rees, G.J.; Ross, CM. Abscopal regression following radiotherapy for adenocarcinoma. Br. J. Radiol. 1983, 56, 63-66.
185. Sham, R.L. The abscopal effect and chronic lymphocytic leukemia. Am. J. Med. 1995, 98, 307-308.
186. Ohba, K.; Omagari, K.; Nakamura, T.; Ikuno, N; Saeki, S.; Matsuo, I.; Kinoshita, H.; Masuda, J.; Hazama, H.; Sakamoto, I.; et al. Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis. Gut 1998, 43, 575-577.
187. Takaya, M.; Niibe, Y.; Tsunoda, S.; Jobo, T.; Imai, M.; Kotani, S.; Unno, N.; Hayakawa, K. Abscopal effect of radiation on toruliform para-aortic lymph node metastases of advanced uterine cervical carcinoma-A case report. Anticancer Res. 2007, 27, 499-503.
188. Okuma, K.; Yamashita, H.; Niibe, Y.; Hayakawa, K.; Nakagawa, K. Abscopal effect of radiation on lung metastases of hepatocellular carcinoma: A case report. J. Med. Case Reports 2011, 5, 111.
189. Perego, D.; Faravelli, A. Unexpected consequence of splenectomy in composite lymphoma. The abscopal effect. Haematologica 2000, 85, 211.
190. Vartak, S.; George, K.C.; Singh, B.B. Antitumor effects of local hyperthermia on a mouse fibrosarcoma. Anticancer Res. 1993, 13, 727-729.
191. Formenti, S.C.; Demaria, S. Systemic effects of local radiotherapy. Lancet Oncol. 2009, 10, 718-726.
192. Dewan, M.Z.; Galloway, A.E.; Kawashima, N.; Dewyngaert, J.K.; Babb, J.S.; Formenti, S.C.; Demaria, S. Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. Clin. Cancer Res. 2009, 15, 5379-5388.
193. Demaria, S.; Ng, B.; Devitt, M.L.; Babb, J.S.; Kawashima, N.; Liebes, L.; Formenti, S.C. Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Int. J. Radiat. Oncol. Biol. Phys. 2004, 58, 862-870.
194. Camphausen, K.; Moses, M.A.; Ménard, C.; Sproull, M.; Beecken, W.D.; Folkman, J.; O'Reilly, M.S. Radiation abscopal antitumor effect is mediated through p53. Cancer Res. 2003, 63, 1990-1993.
195. Kinashi, Y.; Tanaka, H.; Masunaga, S.; Suzuki, M.; Kashino, G.; Yong, L.; Takahashi, S.; Ono, K. Ascorbic acid 2-glucocide reduces micronucleus induction in distant splenic T lymphocytes following head irradiation. Mutat. Res. 2010, 695, 69-74.
196. Ilnytskyy, Y.; Kovalchuk, O. Non-targeted radiation effects-an epigenetic connection. Mutat. Res. 2011, 714, 113-125.
197. Kaminski, J.M.; Shinohara, E.; Summers, J.B.; Niermann, K.J.; Morimoto, A.; Brousal, J. The controversial abscopal effect. Cancer Treat. Rev. 2005, 31, 159-172.
198. Joiner, M.C.; Marples, B.; Lambin, P.; Short, S.C.; Turesson, I. Low-dose hypersensitivity: Current status and possible mechanisms. Int. J. Radiat. Oncol. Biol. Phys. 2001, 49, 379-389.
199. Mortazavi, S.M.J.; Ikushima, T.; Mozdarani, H. Variablity of chromosomal radioadaptive response in human lymphocytes. Iran. J. Radiat. Res. 2003, 1, 55-61.
200. Kadhim, M.A.; Moore, S.R.; Goodwin, E.H. Interrelationships amongst radiation-induced genomic instability, bystander effects, and the adaptive response. Mutat. Res. 2004, 568, 21-32.